{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:25:54Z","timestamp":1788827154132,"version":"build-2803163510"},"reference-count":21,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Introduction: Persistent human papillomavirus (HPV) semen infection is increasingly associated with male infertility. Adjuvant HPV vaccination is suggested to reduce the time to clearance and the disease relapse in males with persistent HPV semen infection. However, only a sub-population of patients show a clinical benefit from adjuvant vaccination. Here, we aimed to address the effectiveness rate of HPV adjuvant vaccination in males with genital tract infection and the possible prognostic markers of healing. Methods: Clinical records from 379 patients with persistent seminal HPV detection, all receiving HPV adjuvant vaccination, were considered. Clinical data, including genital HPV-DNA assessment by INNO-LiPA genotyping, semen HPV-DNA analysis by FISH analysis and serum antibody titer, were collected at basal (T0) and after 6 months (T1) since the vaccination cycle ended. Results: Clearance of genital HPV-DNA was recorded in 326 (86%) patients. Serum HPV-antibody titer at T1 was the most important prognostic factor associated with HPV-DNA clearance. A serum antibody titer equal to or greater than the threshold value 1:125, obtained by ROC curve analysis, was prognostic of healing. Conclusions: Anti-HPV antibody represents a suitable marker of adequate immune response to HPV vaccination in patients with genital infection.<\/jats:p>","DOI":"10.3390\/vaccines8040743","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T12:24:39Z","timestamp":1607343879000},"page":"743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum Anti-HPV Antibody Titer as a Marker of Vaccine Effectiveness in Males with Genital Infection"],"prefix":"10.3390","volume":"8","author":[{"given":"Luca","family":"De Toni","sequence":"first","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muscianisi","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Corsini","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ghezzi","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-9210","authenticated-orcid":false,"given":"Andrea","family":"Di Nisio","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6576-2183","authenticated-orcid":false,"given":"Carlo","family":"Foresta","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-9051","authenticated-orcid":false,"given":"Andrea","family":"Garolla","sequence":"additional","affiliation":[{"name":"Unit of Andrology and Reproductive Medicine, Section of Endocrinology, Department of Medicine, Centre for Male Gamete Cryopreservation, University of Padova, 35122 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: A systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-\u00c1lvarez, M.I., G\u00f3mez-Urquiza, J.L., Husein-El Ahmed, H., Luis Albend\u00edn-Garc\u00eda, L., Juan G\u00f3mez-Salgado, J., and Ca\u00f1adas-De la Fuente, G.A. (2018). Prevalnce and risk factors of Human Papillomavirus in male patients: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15102210"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Andino, J., Buck, C.B., and Ribbeck, K. (2009). Adsorption of human papillomavirus 16 to live human sperm. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005847"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2012.09.006","article-title":"Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patients","volume":"99","author":"Garolla","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40618-019-01069-8","article-title":"High Rate of Detection of Ultrasound Signs of Prostatitis in Patients with HPV-DNA Persistence on Semen: Role of Ultrasound in HPV-related Male Accessory Gland Infection","volume":"42","author":"Condorelli","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0897.1994.tb00849.x","article-title":"Risk factors for antisperm antibodies in infertile men","volume":"31","author":"Heidenreich","year":"1994","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.fertnstert.2015.09.018","article-title":"Spontaneous fertility and in vitro fertilization outcome: New evidence of human papillomavirus sperm infection","volume":"105","author":"Garolla","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","article-title":"Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses","volume":"221","author":"Markowitz","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Draper, E., Bissett, S.L., Howell-Jones, R., Waight, P., Soldan, K., Jit, M., Andrews, N., Miller, E., and Beddows, S. (2013). A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix and Gardasil Human Papillomavirus Vaccines in 12\u201315 Year Old Girls. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061825"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/jiw359","article-title":"Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results from the Mid-Adult Male Vaccine Trial","volume":"214","author":"Pinto","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and metanalysis","volume":"12","author":"Drolet","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1016\/j.vaccine.2018.09.027","article-title":"Therapeutic Human Papillomavirus Vaccines in Head and Neck Cancer: A Systematic Review of Current Clinical Trials","volume":"36","author":"Schneider","year":"2018","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Del Pino, M., Mart\u00ed, C., Torras, I., Henere, C., Munmany, M., Marimon, L., Saco, A., Torn\u00e9, A., and Ordi, J. (2020). HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions. Vaccines, 8.","DOI":"10.3390\/vaccines8020245"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ebiom.2015.09.005","article-title":"HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection","volume":"2","author":"Foresta","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Harder, T., Wichmann, O., Klug, S.J., Van Der Sande, M.A.B., and Wiese-Posselt, M. (2018). Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: A systematic review. BMC Med., 16.","DOI":"10.1186\/s12916-018-1098-3"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e190819","DOI":"10.1001\/jamanetworkopen.2019.0819","article-title":"Effect of human papillomavirus vaccine to interrupt recurrence of vulvar and anal neoplasia (VIVA). A trial control","volume":"2","author":"Karita","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.vaccine.2011.07.007","article-title":"The first international standard for antibodies to HPV 16","volume":"29","author":"Ferguson","year":"2011","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/hv.27619","article-title":"Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination","volume":"10","author":"Zhao","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/infdis\/jir242","article-title":"Serum antibody response following genital {alpha}9 human papillomavirus infection in young men","volume":"204","author":"Edelstein","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4161\/hv.21818","article-title":"Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule","volume":"8","author":"Han","year":"2012","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:50Z","timestamp":1760179310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040743"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040743","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}